Meaghan Granger Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Myeloablative busulfan/melphalan (BuMel) consolidation following induction chemotherapy for patients with high-risk neuroblastoma. A Children’s Oncology Group (COG) study. — Parallel 10 High Risk Neuroblastoma